{"disease":{"id":"generalized-anxiety","name":"generalized anxiety"},"drugs":{"marketed":[{"drug_id":"prochlorperazine-maleate","indication_name":"Generalized Non-Psychotic Anxiety","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PROCHLORPERAZINE MALEATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"duloxetine","indication_name":"Generalized anxiety disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cymbalta","generic_name":"duloxetine","company_name":"Eli Lilly and Company","drug_phase":"marketed","molecular_target":"Serotonin and norepinephrine reuptake","drug_class":"Serotonin and norepinephrine reuptake inhibitor (SNRI)","quality_score":68,"revenue":null,"mechanism":"Potentiates serotonergic and noradrenergic activity in the CNS through unknown exact mechanisms."},{"drug_id":"paroxetine","indication_name":"Generalized Anxiety Disorder (GAD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Paroxetine","generic_name":"paroxetine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Serotonin (5-HT) reuptake transporter","drug_class":"Selective Serotonin Reuptake Inhibitor (SSRI)","quality_score":73,"revenue":null,"mechanism":"Inhibits neuronal reuptake of serotonin in the central nervous system, presumed mechanism for treating psychiatric disorders."},{"drug_id":"bat","indication_name":"Treatment of generalized anxiety disorder in adults","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bat","generic_name":"bat","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Unknown","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"escitalopram","indication_name":"Generalized anxiety disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lexapro","generic_name":"escitalopram","company_name":"Generic (originally Lundbeck/Forest)","drug_phase":"marketed","molecular_target":"Serotonin (5-HT) reuptake transporter","drug_class":"Selective Serotonin Reuptake Inhibitor (SSRI)","quality_score":61,"revenue":null,"mechanism":"Inhibits CNS neuronal reuptake of serotonin (5-HT), potentiating serotonergic activity."},{"drug_id":"venlafaxine","indication_name":"Generalized anxiety disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Effexor","generic_name":"venlafaxine","company_name":"Generic (originally Wyeth/Pfizer)","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2C","drug_class":"SNRI (Serotonin-norepinephrine reuptake inhibitor)","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"effexor-xr","indication_name":"Generalized anxiety disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Effexor","generic_name":"Venlafaxine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Serotonin and norepinephrine reuptake transporters","drug_class":"Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)","quality_score":70,"revenue":null,"mechanism":"Potentiates serotonin and norepinephrine in CNS through reuptake inhibition."},{"drug_id":"citalopram","indication_name":"Generalized anxiety disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Celexa","generic_name":"CITALOPRAM","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Sodium-dependent serotonin transporter","drug_class":"Serotonin Reuptake Inhibitor","quality_score":80,"revenue":null,"mechanism":"Celexa works by blocking the reabsorption of serotonin in the brain, allowing more of this neurotransmitter to be available for communication between nerve cells."},{"drug_id":"buspirone","indication_name":"Generalized anxiety disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Buspar","generic_name":"BUSPIRONE","company_name":"","drug_phase":"marketed","molecular_target":"D(2) dopamine receptor","drug_class":"buspirone","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"effexor","indication_name":"Generalized anxiety disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Effexor","company_name":"Wyeth is now a wholly owned subsidiary of Pfizer","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2C","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"cital","indication_name":"Generalized anxiety disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cital","company_name":"Ain Shams University","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"xanax","indication_name":"Generalized anxiety disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Xanax","company_name":"National Taiwan University Hospital","drug_phase":"marketed","molecular_target":"Bromodomain-containing protein 4, Platelet-activating factor receptor, Cytochrome P450 3A4","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"alprazolam","indication_name":"Generalized anxiety disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xanax","generic_name":"alprazolam","company_name":"Generic (originally Upjohn/Pfizer)","drug_phase":"marketed","molecular_target":"Bromodomain-containing protein 4, Platelet-activating factor receptor, Cytochrome P450 3A4","drug_class":"Benzodiazepine (triazolobenzodiazepine)","quality_score":0,"revenue":null,"mechanism":"Short-acting, high-potency benzodiazepine that enhances GABA-A receptor activity, providing rapid anxiolytic relief."}],"pipeline":[],"offLabel":[],"totalMarketed":13,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04356365","title":"The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's)","phase":"","overall_status":"COMPLETED","enrollment_count":10084,"lead_sponsor_name":"University of Oslo","has_results":false},{"nct_id":"NCT07305701","title":"Cohort Study on Medical Students' Mental Health","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Centre Hospitalier Régional d'Orléans","has_results":false},{"nct_id":"NCT04806620","title":"Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Brain Inflammation Collaborative","has_results":false},{"nct_id":"NCT06512324","title":"Operation of Brain Stimulation Equipment Under Remote Viewing Effectiveness Registry","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":5000,"lead_sponsor_name":"Biomedical Discoveries and Neuroscientific Foundations LLC","has_results":false},{"nct_id":"NCT04442360","title":"The Impact of Information Sources on Mental Health During the COVID-19 Pandemic","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"University of Oslo","has_results":false},{"nct_id":"NCT04433832","title":"Physical and Psychological Health Trajectories in the Context of Coronary Heart Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":3610,"lead_sponsor_name":"Laval University","has_results":false},{"nct_id":"NCT07129408","title":"Epidemiological Study on the Prevalence of Mental Disorders in Slovakia","phase":"","overall_status":"COMPLETED","enrollment_count":3100,"lead_sponsor_name":"Comenius University","has_results":false},{"nct_id":"NCT05800925","title":"Triage Survey for Psychiatry Research Eligibility","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Adams Clinical","has_results":false},{"nct_id":"NCT05411302","title":"Augmenting Mental Health Support Through a Supportive Text Messaging Program","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Vincent Agyapong","has_results":false},{"nct_id":"NCT05108220","title":"Evaluation of Effects of CBD Products on Anxiety Among U.S. Women","phase":"","overall_status":"COMPLETED","enrollment_count":1350,"lead_sponsor_name":"Radicle Science","has_results":false},{"nct_id":"NCT04900064","title":"Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":1242,"lead_sponsor_name":"Linnaeus University","has_results":false},{"nct_id":"NCT03829241","title":"Randomized Trial of Adult Participants With Generalized Anxiety Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":881,"lead_sponsor_name":"Biohaven Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT01629966","title":"Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":680,"lead_sponsor_name":"Forest Laboratories","has_results":true},{"nct_id":"NCT05467683","title":"CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"University of Texas at Austin","has_results":false},{"nct_id":"NCT06942429","title":"Stepped Versus Stratified Care for Anxiety Disorders in Youth","phase":"NA","overall_status":"RECRUITING","enrollment_count":556,"lead_sponsor_name":"Region Skane","has_results":false},{"nct_id":"NCT05970510","title":"A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":555,"lead_sponsor_name":"Luye Pharma Group Ltd.","has_results":false},{"nct_id":"NCT06243640","title":"Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":504,"lead_sponsor_name":"Beijing Union Pharmaceutical Factory Ltd","has_results":false},{"nct_id":"NCT06934525","title":"Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings","phase":"NA","overall_status":"RECRUITING","enrollment_count":501,"lead_sponsor_name":"Bradley Hospital","has_results":false},{"nct_id":"NCT05772104","title":"Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":495,"lead_sponsor_name":"Sichuan Jishengtang Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04598230","title":"Partners in Caring for Anxious Youth","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":468,"lead_sponsor_name":"Ann & Robert H Lurie Children's Hospital of Chicago","has_results":false},{"nct_id":"NCT07201844","title":"The Effect of Patient Preference for Treatment Model in Internet Delivered Cognitive Behavior Therapy for Generalized Anxiety Disorder","phase":"NA","overall_status":"RECRUITING","enrollment_count":440,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT05729373","title":"A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":434,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":false},{"nct_id":"NCT01844115","title":"Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":415,"lead_sponsor_name":"Forest Laboratories","has_results":true},{"nct_id":"NCT05124639","title":"Clinical Trial of a Group Self-management Support Program for Anxiety Disorders","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":414,"lead_sponsor_name":"Université de Sherbrooke","has_results":false},{"nct_id":"NCT06243614","title":"Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":410,"lead_sponsor_name":"Beijing Union Pharmaceutical Factory Ltd","has_results":false},{"nct_id":"NCT01766401","title":"Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":402,"lead_sponsor_name":"Forest Laboratories","has_results":true},{"nct_id":"NCT05849493","title":"Effects and Mechanisms of Change of Internet Delivered Cognitive Behavior Therapy for Generalized Anxiety Disorder","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT03188575","title":"Effectiveness & Cost-effectiveness of Internet-delivered Interventions for Depression and Anxiety Disorders in IAPT","phase":"NA","overall_status":"UNKNOWN","enrollment_count":384,"lead_sponsor_name":"Silver Cloud Health","has_results":false},{"nct_id":"NCT04562948","title":"Community Applications of the MindShift App","phase":"","overall_status":"COMPLETED","enrollment_count":380,"lead_sponsor_name":"University of Windsor","has_results":false},{"nct_id":"NCT03528109","title":"Improving Access to Child Anxiety Treatment","phase":"NA","overall_status":"UNKNOWN","enrollment_count":379,"lead_sponsor_name":"Bradley Hospital","has_results":false},{"nct_id":"NCT04811521","title":"Patient-centered Treatment of Anxiety After Low-Risk Chest Pain in the Emergency Room","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":375,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT05016050","title":"Digital Therapeutic for Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD)","phase":"NA","overall_status":"COMPLETED","enrollment_count":367,"lead_sponsor_name":"Happify Inc.","has_results":false},{"nct_id":"NCT03491384","title":"Anxiety, Inflammation, Stress, and Cannabinoids","phase":"","overall_status":"COMPLETED","enrollment_count":361,"lead_sponsor_name":"University of Colorado, Boulder","has_results":true},{"nct_id":"NCT05748652","title":"Generalized Anxiety Therapy Effectiveness","phase":"NA","overall_status":"COMPLETED","enrollment_count":351,"lead_sponsor_name":"Big Health Inc.","has_results":false},{"nct_id":"NCT05717439","title":"Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults with PTSD","phase":"","overall_status":"COMPLETED","enrollment_count":338,"lead_sponsor_name":"Senseye, Inc.","has_results":false},{"nct_id":"NCT07452835","title":"Transcranial Direct Current Stimulation (tDCS) in Different Psychiatric Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":320,"lead_sponsor_name":"Menoufia University","has_results":false},{"nct_id":"NCT06973577","title":"P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":315,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":false},{"nct_id":"NCT03113175","title":"Collabri Flex - Effect of Collaborative Care for People With Anxiety Disorders in General Practice","phase":"NA","overall_status":"COMPLETED","enrollment_count":302,"lead_sponsor_name":"Amager Hospital","has_results":false},{"nct_id":"NCT04846777","title":"Brief Smartphone Treatment Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Penn State University","has_results":false},{"nct_id":"NCT06071819","title":"Clinical Markers of Panic and Generalized Anxiety Disorder","phase":"","overall_status":"COMPLETED","enrollment_count":290,"lead_sponsor_name":"University of Milano Bicocca","has_results":false},{"nct_id":"NCT03118752","title":"Pragmatic Collaborative Care for Cardiac Inpatients With Depression or Anxiety","phase":"NA","overall_status":"COMPLETED","enrollment_count":290,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT03522844","title":"Treatments for Anxiety: Meditation and Escitalopram","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":276,"lead_sponsor_name":"Georgetown University","has_results":false},{"nct_id":"NCT03585010","title":"Brain Response Associated With Parent-based Treatment for Childhood Anxiety Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":274,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT03924323","title":"A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":273,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT03917550","title":"RECOVERY: A Transdiagnostic Intervention for Anxiety and Depression","phase":"NA","overall_status":"UNKNOWN","enrollment_count":260,"lead_sponsor_name":"West University of Timisoara","has_results":false},{"nct_id":"NCT05117255","title":"Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity","phase":"NA","overall_status":"RECRUITING","enrollment_count":256,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT04386291","title":"Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19","phase":"NA","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"Research Foundation for Mental Hygiene, Inc.","has_results":true},{"nct_id":"NCT05749055","title":"ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":252,"lead_sponsor_name":"Engrail Therapeutics INC","has_results":false},{"nct_id":"NCT02811458","title":"Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":231,"lead_sponsor_name":"Université de Sherbrooke","has_results":false},{"nct_id":"NCT00586586","title":"Effectiveness Study of CBT for Anxiety in Children","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":222,"lead_sponsor_name":"Haukeland University Hospital","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}